FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40356211000001109: Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Dec 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1295301000001116 Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1295321000001111 Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Has AMP Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Is a Calcipotriol 0.005% / Betamethasone dipropionate 0.05% cream 60 gram true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Has excipient Butylated hydroxyanisole false Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Has dispensed dose form Cream true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Has specific active ingredient Calcipotriol true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Wynzora 50micrograms/g / 0.5mg/g cream (Almirall Ltd) 60 gram Has excipient Excipient not declared true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start